BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28545168)

  • 1. Reliability of the triple-timed up-and-go test.
    Sanders DB; Guptill JT; Aleš KL; Hobson-Webb LD; Jacobus DP; Mahmood R; Massey JM; Pittman MM; Prather K; Raja SM; Yow E; Juel VC
    Muscle Nerve; 2018 Jan; 57(1):136-139. PubMed ID: 28545168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia.
    Raja SM; Sanders DB; Juel VC; Harati Y; Smith AG; Pascuzzi R; Richman DP; Wu A; Aleš KL; Jacobus LR; Jacobus DP; Guptill JT;
    Muscle Nerve; 2019 Sep; 60(3):292-298. PubMed ID: 31269226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.
    Sanders DB; Juel VC; Harati Y; Smith AG; Peltier AC; Marburger T; Lou JS; Pascuzzi RM; Richman DP; Xie T; Demmel V; Jacobus LR; Aleš KL; Jacobus DP;
    Muscle Nerve; 2018 Apr; 57(4):561-568. PubMed ID: 29280483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia.
    Thakkar N; Guptill JT; Aleš K; Jacobus D; Jacobus L; Peloquin C; Cohen-Wolkowiez M; Gonzalez D;
    CPT Pharmacometrics Syst Pharmacol; 2017 Sep; 6(9):625-634. PubMed ID: 28623849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J
    Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lambert-Eaton syndrome or mixed neuromuscular block: diagnostic difficulties].
    Lefebvre P; Mavroudakis N
    Ann Med Interne (Paris); 1995; 146(1):55-8. PubMed ID: 7741401
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical neurophysiology of disorders of the neuromuscular junction.
    Sanders DB
    J Clin Neurophysiol; 1993 Apr; 10(2):167-80. PubMed ID: 8389381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lambert-Eaton myasthenic syndrome in children.
    Tsao CY; Mendell JR; Friemer ML; Kissel JT
    J Child Neurol; 2002 Jan; 17(1):74-6. PubMed ID: 11913581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up in infantile-onset lambert-eaton myasthenic syndrome.
    Portaro S; Parisi D; Polizzi A; Ruggieri M; Andreetta F; Bernasconi P; Toscano A; Rodolico C
    J Child Neurol; 2014 Sep; 29(9):NP58-61. PubMed ID: 24114606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Sanders DB; Guptill JT
    Continuum (Minneap Minn); 2014 Oct; 20(5 Peripheral Nervous System Disorders):1413-25. PubMed ID: 25299290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which diagnostics are essential in patients with neuromuscular diseases?].
    Bischoff P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jul; 38(7):488-91. PubMed ID: 12822123
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review.
    Alboini PE; Damato V; Iorio R; Luigetti M; Evoli A
    Neuromuscul Disord; 2015 Aug; 25(8):646-50. PubMed ID: 26028274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis Lambert-Eaton overlap syndrome.
    Oh SJ
    Muscle Nerve; 2016 Jan; 53(1):20-6. PubMed ID: 26418033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-fiber EMG with concentric electrodes in lambert-eaton myasthenia.
    Guan Y; Ding Q; Liu M; Niu J; Cui L
    Muscle Nerve; 2017 Aug; 56(2):253-257. PubMed ID: 27935068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurophysiological testing in myasthenia syndromes].
    Kostera-Pruszczyk A; Rowińska-Marcińska K; Emeryk-Szajewska B
    Neurol Neurochir Pol; 2003; 37(1):161-72. PubMed ID: 12910838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome.
    Howard JF; Sanders DB; Massey JM
    Neurol Clin; 1994 May; 12(2):305-30. PubMed ID: 8041344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome.
    Wirtz PW; Sotodeh M; Nijnuis M; Van Doorn PA; Van Engelen BG; Hintzen RQ; De Kort PL; Kuks JB; Twijnstra A; De Visser M; Visser LH; Wokke JH; Wintzen AR; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):766-8. PubMed ID: 12438488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular aggregates in autoimmune Lambert-Eaton myasthenic syndrome.
    Cordts I; Funk F; Schulz JB; Weis J; Claeys KG
    Neuromuscul Disord; 2016 Dec; 26(12):880-884. PubMed ID: 27816328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.